Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DYDROGESTERONE vs ECULIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DYDROGESTERONE vs ECULIZUMAB: Safety Overview

Metric DYDROGESTERONE ECULIZUMAB
Total FAERS Reports 340 44,190
Deaths Reported 13 4,626
Death Rate 3.8% 10.5%
Hospitalizations 112 12,421
Average Patient Age 33.8 yrs 42.6 yrs
% Female Patients 94.4% 59.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer N/A Alexion Pharmaceuticals Inc.
Route N/A INTRAVENOUS
Marketing Status Discontinued Prescription